|
1
|
Polakis P: Wnt signaling in cancer. Cold
Spring Harb Perspect Biol. 4:a0080522012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Munemitsu S, Albert I, Souza B, Rubinfeld
B and Polakis P: Regulation of intracellular betacatenin levels by
the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc
Natl Acad Sci USA. 92:3046–3050. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moody CA and Laimins LA: Human
papillomavirus oncoproteins: Pathways to transformation. Nat Rev
Cancer. 10:550–560. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Uren A, Fallen S, Yuan H, Usubütün A,
Kücükali T, Schlegel R and Toretsky JA: Activation of the canonical
Wnt pathway during genital keratinocyte transformation: A model for
cervical cancer progression. Cancer Res. 65:6199–6206. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bulut G, Fallen S, Beauchamp EM, Drebing
LE, Sun J, Berry DL, Kallakury B, Crum CP, Toretsky JA, Schlegel R
and Üren A: Beta-catenin accelerates human papilloma virus type-16
mediated cervical carcinogenesis in transgenic mice. PLoS One.
6:e272432011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rodríguez-Sastre M, González-Maya L,
Delgado R, Mohar A and García-Carrancá A: Abnormal distribution of
E-cadherin and β-catenin in different histologic types of cancer of
the uterine cervix. Gynecol Oncol. 97:330–336. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shinohara A, Yokoyama Y, Wan X, Takahashi
Y, Mori Y, Takami T, Shimokawa K and Tamaya T: Cytoplasmic/nuclear
expression without mutation of exon 3 of the beta-catenin gene is
frequent in the development of the neoplasm of the uterine cervix.
Gynecol Oncol. 82:450–455. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pereira-Suárez A, Meraz MA, Lizano M,
Estrada-Chávez C, Hernández F, Olivera P, Pérez E, Padilla P, Yaniv
M, Thierry F and García-Carrancá A: Frequent alterations of the
beta-catenin protein in in cancer of the uterine cervix. Tumor
Biol. 23:45–53. 2002. View Article : Google Scholar
|
|
10
|
Nakamura Y, Nishisho I, Kinzler KW,
Vogelstein B, Miyoshi Y, Miki Y, Ando H, Horii A and Nagase H:
Mutations of the adenomatous polyposis coli gene in familial
polyposis coli patients and sporadic colorectal tumors. Princess
Takamatsu Symp. 22:285–292. 1991.PubMed/NCBI
|
|
11
|
Horii A, Nakatsuru S, Miyoshi Y, Ichii S,
Nagase H, Kato Y, Yanagisawa A and Nakamura Y: The APC gene,
responsible for familial adenomatous polyposis, is mutated in human
gastric cancer. Cancer Res. 152:3231–3233. 1992.
|
|
12
|
Tsuchiya T, Tamura G, Sato K, Endoh Y,
Sakata K, Jin Z, Motoyama T, Usuba O, Kimura W, Nishizuka S, et al:
Distinct methylation patterns of two APC gene promoters in normal
and cancerous gastric epithelia. Oncogene. 19:3642–3646. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hosoya K, Yamashita S, Ando T, Nakajima T,
Itoh F and Ushijima T: Adenomatous polyposis coli 1A is likely to
be methylated as a passenger in human gastric carcinogenesis.
Cancer Lett. 285:182–189. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Javadi A, Shamaei M, Ziazi Mohammadi L,
Pourabdollah M, Dorudinia A, Seyedmehdi SM and Karimi S:
Qualification study of two genomic DNA extraction methods in
different clinical samples. Tanaffos. 13:41–47. 2014.PubMed/NCBI
|
|
15
|
Miyoshi Y, Ando H, Nagase H, Nishisho I,
Horii A, Miki Y, Mori T, Utsunomiya J, Baba S, Petersen G, et al:
Germ-line mutations of the APC gene in 53 familial adenomatous
polyposis patients. Proc Natl Acad Sci USA. 89:4452–4456. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Esteller M, Sparks A, Toyota M,
Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G,
Sidransky D, Meltzer SJ, et al: Analysis of adenomatous polyposis
coli promoter hypermethylation in human cancer. Cancer Res.
60:4366–4371. 2000.PubMed/NCBI
|
|
17
|
Rowan AJ, Lamlum H, Ilyas M, Wheeler J,
Straub J, Papadopoulou A, Bicknell D, Bodmer WF and Tomlinson IP:
APC mutations in sporadic colorectal tumors: A mutational ‘hotspot’
and interdependence of the ‘two hits’. Proc Natl Acad Sci USA.
97:3352–3357. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Minde DP, Anvarian Z, Rüdiger SG and
Maurice MM: Messing up disorder: How do missense mutations in the
tumor suppressor protein APC lead to cancer? Mol Cancer.
10:1012011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hiltunen M, Alhonen L, Koistinaho J,
Myöhänen S, Pääkkönen M, Marin S, Kosma VM and Jänne J:
Hypermethylation of the APC (adenomatous polyposis coli) gene
promoter region in human colorectal carcinoma. Int J Cancer.
70:644–648. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Virmani A, Rathi A, Sathyanarayana U,
Padar A, Huang C, Cunnigham H, Farinas A, Milchgrub S, Euhus D,
Gilcrease M, et al: Aberrant methylation of the adenomatous
polyposis coli (APC) gene promoter 1A in breast and lung
carcinomas. Clin Cancer Res. 7:1998–2004. 2001.PubMed/NCBI
|
|
21
|
Aguiler O, Muñoz A, Esteller M and Fraga
M: Epigenetic alterations of the Wnt/beta-catenin pathway in human
disease. Endocr Metab Immune Disord Drug Targets. 7:13–21. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kikuchi A: Tumor formation by genetic
mutations in the components of the Wnt signaling pathway. Cancer
Sci. 94:225–229. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Morin PJ, Sparks AB, Korinek V, Barker N,
Clevers H, Vogelstein B and Kinzler KW: Activation of
beta-catenin-Tcf signaling in colon cancer by mutations in
beta-catenin or APC. Science. 275:1787–1790. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cieply B, Zeng G, Proverbs-Singh T, Geller
DA and Monga SP: Unique phenotype of hepatocellular cancers with
exon-3 mutations in beta-catenin gene. Hepatology. 49:821–31. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roberts DM, Pronobis MI, Poulton JS,
Waldmann JD, Stephenson EM, Hanna S and Peifer M: Deconstructing
the ßcatenin destruction complex: Mechanistic roles for the tumor
suppressor APC in regulating Wnt signaling. Mol Biol Cell.
22:1845–1863. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bai A, Tong J, To K, Chan M, Man E, Lo K,
Lee J, Sung J and Leung W: Promoter hypermethylation of
tumor-related genes in the progression of colorectal neoplasia. Int
J Cancer. 112:846–853. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu X, Li J, Li K, Tian X and Zhang Y:
Hypermethylation of APC promoter 1A is associated with moderate
activation of Wnt signalling pathway in a subset of colorectal
serrated adenomas. Histopathology. 55:554–563. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kang S, Kim J, Kang G, Lee S, Park N, Song
Y, Park S, Kang S and Lee H: Comparison of DNA hypermethylation
patterns in different types of uterine cancer: Cervical squamous
cell carcinoma, cervical adenocarcinoma and endometrial
adenocarcinoma. Int J Cancer. 118:2168–2171. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang N, Nijhuis E, Volders H, Eijsink J,
Lendvai A, Zhang B, Hollema H, Schuuring E, Wisman G and van der
Zeea A: Gene promoter methylation patterns throughout the process
of cervical carcinogenesis. Cell Oncol. 32:131–143. 2010.PubMed/NCBI
|
|
30
|
Zambrano P, Segura-Pacheco B,
Perez-Cardenas E, Cetina L, Revilla-Vazquez A, Taja-Chayeb L,
Chavez-Blanco A, Angeles E, Cabrera G, Sandoval K, et al: A phase I
study of hydralazine to demethylate and reactivate the expression
of tumor suppressor genes. BMC Cancer. 5:442005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dong S, Kim H, Rha S and Sidransky D:
Promoter hypermethylation of multiple genes in carcinoma of the
uterine cervix. Clin Cancer Res. 7:982–1986. 2001.
|
|
32
|
Wisman GB, Nijhuis ER, Hoque MQ,
Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM,
Hollema H, Schuuring E, et al: Assessment of gene promoter
hypermethylation for detection of cervical neoplasia. Int J Cancer.
119:1908–1914. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van der Meide WF, Snellenberg S, Meijer
CJ, Baalbergen A, Helmerhorst TJ, van der Sluis WB, Snijders PJ and
Steenbergen RD: Promoter methylation analysis of WNT/β-catenin
signaling pathway regulators to detect adenocarcinoma or its
precursor lesion of the cervix. Gynecol Oncol. 123:116–122. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma C, Zeng C, Jin L, Yang Y, Li P, Chen L
and Wang J: GSK3β mediates the carcinogenic effect of HPV16 in
cervical cancer. Sci Rep. 5:165552015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cameron EE, Bachman KE, Myöhänen S, Herman
JG and Baylin SB: Synergy of demethylation and histone deacetylase
inhibition in the re-expression of genes silenced in cancer. Nat
Genet. 21:103–107. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang X, Phillips DL, Ferguson AT, Nelson
WG, Herman JG and Davidson NE: Synergistic activation of functional
estrogen receptor (ER)-alpha by DNA methyltransferase and histone
deacetylase inhibition in human ER-alpha-negative breast cancer
cells. Cancer Res. 61:7025–7029. 2001.PubMed/NCBI
|
|
37
|
Worm J, Christensen C, Grønbaek K,
Tulchinsky E and Guldberg P: Genetic and epigenetic alterations of
the APC gene in malignant melanoma. Oncogene. 23:5215–5226. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chung MT, Lai HC, Sytwu HK, Yan MD, Shih
YL, Chang CC, Yu MH, Liu HS, Chu DW and Lin YW: SFRP1 and SFRP2
suppress the transformation and invasion abilities of cervical
cancer cells through Wnt signal pathway. Gynecol Oncol.
112:646–653. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Korinek V, Barker N, Morin PJ, van Wichen
D, de Weger R, Kinzler KW, Vogelstein B and Clevers H: Constitutive
transcriptional activation by a beta-catenin-Tcf complex in
APC−/−colon carcinoma. Science. 275:1784–1787. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Svedlund J, Aurén M, Sundström M, Dralle
H, Akerström G, Björklund P and Westin G: Aberrant WNT/β-catenin
signaling in parathyroid carcinoma. Mol Cancer. 9:2942010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang M, Wang Y, Sun D, Zhu H, Yin Y,
Zhang W, Yang S, Quan L, Bai J, Wang S, et al: Identification of
genes regulated by Wnt/beta-catenin pathway and involved in
apoptosis via microarray analysis. BMC Cancer. 6:2212006.
View Article : Google Scholar : PubMed/NCBI
|
